Susquehanna International Group
JUNO

Susquehanna International Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

Susquehanna International Group’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-352,027
Closed -$16.1M – 10807
2017
Q4 		$16.1M Buy
352,027
+66,266
+23% +$3.31M 0.01% 1415
2017
Q3 		$12.8M Buy
285,761
+239,287
+515% +$8.16M 0.01% 1564
2017
Q2 		$1.39M Sell
46,474
-182,301
-80% -$4.5M ﹤0.01% 4586
2017
Q1 		$5.08M Sell
228,775
-205,887
-47% -$4.42M ﹤0.01% 2340
2016
Q4 		$8.19M Buy
434,662
+282,373
+185% +$6.91M ﹤0.01% 1757
2016
Q3 		$4.57M Buy
152,289
+51,117
+51% +$1.59M ﹤0.01% 2352
2016
Q2 		$3.89M Sell
101,172
-14,724
-13% -$611K ﹤0.01% 2550
2016
Q1 		$4.41M Sell
115,896
-6,363
-5% -$222K ﹤0.01% 2464
2015
Q4 		$5.38M Sell
122,259
-218,857
-64% -$10.9M ﹤0.01% 2442
2015
Q3 		$13.9M Buy
341,116
+258,598
+313% +$11.3M 0.01% 1522
2015
Q2 		$4.4M Buy
82,518
+26,278
+47% +$1.39M ﹤0.01% 3122
2015
Q1 		$3.41M Buy
56,240
+51,223
+1,021% +$2.49M ﹤0.01% 3322
2014
Q4 		$262K Buy
+5,017
New +$225K ﹤0.01% 8364

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Susquehanna International Group's JUNO Position: Q1 2018 in Review

Susquehanna International Group sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 352,027 shares — an estimated $16.1M sold.

Susquehanna International Group first reported a position in JUNO in Q4 2014 and held it in 13 quarters. The position peaked at $16.1M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Susquehanna International Group reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 352,027 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $16.1M.
  • Susquehanna International Group first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
  • Susquehanna International Group's Juno Therapeutics, Inc. position peaked at $16.1M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.